SCHEMBL7519384

SCHEMBL7519384

CCOC(=O)C[C@H](NC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
MAPT P10636 10/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
GAA P10253 2/20 0.54
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TP53 P04637 1/20 0.48
CRHBP P24387 2/20 0.48
CRHR2 Q13324 2/20 0.48
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.46
CA2 P00918 1/20 0.46
MEN1 O00255 2/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519380 1.00 LMNA (0.56) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL7775216 0.88 ALDH1A1 (0.55) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL7954574 0.88 ALDH1A1 (0.55) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL7954572 0.88 ALDH1A1 (0.55) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL2852865 0.82 LMNA (0.53) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL18277714 0.82 LMNA (0.50) LMNAALDH1A1KDM4EGAANPC1
SCHEMBL7609219 0.80 RAB9A (0.60) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL3936094 0.80 RAB9A (0.60) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL7513910 0.80 MAPT (0.56) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL1646935 0.78 MAPT (0.67) LMNAMAPTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019496-A1 Ligands for metal affinity chromatography PEVOW GERALD (US) 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019496-A1 Ligands for metal affinity chromatography MLX, RBX1, BRIX1 LMNA 2973/4885MAPT 1963/4885ALDH1A1 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.